GlassScriptPhysician profile
Bao T Pham
NPI 1467445403
$1,709.98
in general payments reported to CMS, 2019-2025
23 companies · $90.96 in 2025
The $90.96 reported for 2025 was less than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $934 · 2020: $220 · 2021: $191 · 2022: $78.36 · 2023: $127 · 2024: $68.55 · 2025: $90.96.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $287.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $286.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amniox Medical, INC. | $698.68 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $179.17 | 2019-2023 | Relistor |
| Novo Nordisk INC | $159.80 | 2023-2025 | Ozempic, Rybelsus |
| Redhill Biopharma INC. | $84.95 | 2020-2022 | |
| Venclose INC. | $82.01 | 2020 | |
| Amgen INC. | $62.74 | 2020 | |
| Medtronic USA, INC. | $54.86 | 2019 | |
| Valinor Pharma, LLC | $37.26 | 2025 | Movantik |
| Forte Bio-Pharma LLC | $34.46 | 2024 | Prolate, Nalocet |
| Opsens INC. | $33.75 | 2019 | |
| Abbott Laboratories | $32.88 | 2022 | |
| Spr Therapeutics, INC | $31.61 | 2024-2025 | Sprint Pns System |
| Si-Bone, INC. | $28.10 | 2021 | |
| Assertio Therapeutics, INC. | $24.85 | 2019 | |
| Abbvie INC. | $22.55 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $21.20 | 2020 | |
| Nalu Medical, INC. | $21.01 | 2021 | |
| Virtus Pharmaceuticals LLC | $19.97 | 2021 | |
| Daiichi Sankyo INC. | $19.12 | 2019 | |
| Kaleo, INC. | $16.36 | 2019 | |
| Scilex Pharmaceuticals INC. | $15.59 | 2019 | |
| Depuy Synthes Sales INC. | $15.15 | 2021 | |
| Mdd US Operations, LLC | $13.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bao Pham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.